Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Financial Ratios

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Financial Ratios History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs) 36.05100.0421.145.5026.29
   CEPS(Rs) 39.7526.5021.6010.3829.16
   DPS(Rs) 32.0090.0030.0040.0020.00
   Book NAV/Share(Rs) 102.89157.1987.26107.47126.31
   Tax Rate(%) 27.3551.1236.7269.5234.76
Margin Ratios
   Core EBITDA Margin(%) 22.5421.2019.1419.5519.21
   EBIT Margin(%) 23.4921.7314.649.2821.84
   Pre Tax Margin(%) 23.4421.6714.539.0921.82
   PAT Margin (%) 17.0310.599.192.7714.24
   Cash Profit Margin (%) 18.8712.4911.715.2315.79
Performance Ratios
   ROA(%) 15.7610.119.521.725.77
   ROE(%) 27.5818.3917.424.7121.22
   ROCE(%) 38.0637.7227.7415.7632.54
   Asset Turnover(x) 0.930.951.040.620.41
   Sales/Fixed Asset(x) 5.756.033.043.346.48
   Working Capital/Sales(x) 3.061.794.684.475.67
Efficiency Ratios
   Fixed Capital/Sales(x) 0.170.170.330.300.15
   Receivable days 20.3421.3718.4211.9615.60
   Inventory Days 50.8754.9160.1452.6257.56
   Payable days 143.05140.69119.53106.45122.52
Valuation Parameters
   PER(x) 36.7316.6268.13226.3449.44
   PCE(x) 33.3162.7566.69119.9444.58
   Price/Book(x) 12.8710.5816.5111.5910.29
   Yield(%) 2.425.412.083.211.54
   EV/Net Sales(x) 6.547.847.946.216.67
   EV/Core EBITDA(x) 23.5130.6732.8027.1829.65
   EV/EBIT(x) 25.3832.8950.8064.1230.52
   EV/CE(x) 6.665.687.726.622.67
   M Cap / Sales 6.908.598.346.547.04
Growth Ratio
   Net Sales Growth(%) -0.8012.05-9.273.088.94
   Core EBITDA Growth(%) 8.0318.19-3.744.7125.48
   EBIT Growth(%) 7.3270.7146.60-54.3226.49
   PAT Growth(%) 59.5832.55208.21-79.0726.99
   EPS Growth(%) -63.97373.19284.26-79.07-36.50
Financial Stability Ratios
   Total Debt/Equity(x) -----
   Current Ratio(x) 1.882.181.491.741.20
   Quick Ratio(x) 1.531.871.091.261.02
   Interest Cover(x) 462.54391.29129.5649.261,232.59
   Total Debt/Mcap(x) -----

Compare Financial Ratios of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹35,355.5 Cr 0.4% 10.9% 71.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

0.4%

10.9%

71.1%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses